NCT01039233

Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting Conditions

Randomized, Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Kremers Urban Development Company · Industry
• Sex: Male
• Age: 20 Years – 73 Years
• Healthy volunteers: Accepted

Summary

The objective of this study is to compare the rate and extent of absorption of bicalutamide 50 mg tablet (test) versus Casodex (reference), administered as 1 x 50 mg tablet under fasting conditions

Conditions

• Bioequivalency

Interventions

Type	Name	Description
DRUG	Bicalutamide 50 mg Tablet vs Casodex® 50 mg Tablet

Timeline

• Start date: 2005-05-01
• Primary completion: 2005-06-01
• Completion: 2005-07-01
• First posted: 2009-12-24
• Last updated: 2009-12-24

Locations

1 site across 1 country: Canada